Cardiac Disease Modeling with Engineered Heart Tissue

Handb Exp Pharmacol. 2023:281:235-255. doi: 10.1007/164_2023_681.

Abstract

The rhythmically beating heart is the foundation of life-sustaining blood flow. There are four chambers and many different types of cell in the heart, but the twisted myofibrillar structures formed by cardiomyocytes are particularly important for cardiac contraction and electrical impulse transmission properties. The ability to generate cardiomyocytes using human-induced pluripotent stem cells has essentially solved the cell supply shortage for in vitro simulation of cardiac tissue function; however, modeling heart at the tissue level needs mature myocardial structure, electrophysiology, and contractile characteristics. Here, the current research on human functionalized cardiac microtissue in modeling cardiac diseases is reviewed and the design criteria and practical applications of different human engineered heart tissues, including cardiac organoids, cardiac thin films, and cardiac microbundles are analyzed. Table summarizing the ability of several in vitro myocardial models to assess heart structure and function for cardiac disease modeling.

Keywords: Cardiomyocytes; Disease modeling; Engineered heart tissue.

Publication types

  • Review

MeSH terms

  • Cell Differentiation
  • Heart Diseases* / metabolism
  • Humans
  • Myocardium
  • Myocytes, Cardiac* / metabolism
  • Tissue Engineering